Article · 2 min read

CJC-1295 DAC in Germany: Legal Status & Context

A factual look at CJC-1295 DAC: how it works, how it differs from the no-DAC variant, and its legal status in Germany.

Reviewed by the Peptica editorial team

Published 5 June 2026

Source-based, neutral information — no medical advice, no sales. Editorial standards

In short: CJC-1295 DAC is not an approved medicine in Germany and is not regularly available in pharmacies. It is an experimental research peptide. This article explains neutrally what the term means, what the “DAC” modification does, and what the legal framework looks like — with no usage or sourcing recommendations.

What is CJC-1295 DAC?

CJC-1295 is a synthetic analog of the body's own growth-hormone-releasing hormone (GHRH). It belongs to a group of substances studied for whether they can prompt the body's own release of growth hormone.

The “DAC” suffix stands for Drug Affinity Complex — a modification that binds the molecule to a blood protein (albumin). This keeps it active in the body markedly longer than the unmodified variant.

CJC-1295 DAC vs. Mod GRF 1-29 (no DAC)

The key difference is duration of action. The variant without DAC — often called Mod GRF 1-29 — has a short half-life and is characterized differently in research than the long-acting DAC version.

  • CJC-1295 DAC: long duration via albumin binding, sustained baseline elevation.
  • Mod GRF 1-29 (no DAC): short, pulsatile action, closer to the natural release pattern.

Legal status in Germany and the EU

CJC-1295 DAC is not approved as a medicine in Germany. There is no finished pharmaceutical product containing it, and it is not regularly available in pharmacies. Products offered online as “for research use only” are not intended for human use.

Anti-doping

GHRH analogs such as CJC-1295 fall under the World Anti-Doping Agency (WADA) prohibited list in sport. For competitive athletes the substance is therefore not permitted.

Research status

Human data on CJC-1295 DAC is limited. Early studies observed an increase in growth hormone and IGF-1 over several days. However, the large controlled clinical trials required for approval are absent. The substance therefore remains experimental.

Frequently asked questions

Is CJC-1295 DAC legal in Germany?+

It is not an approved medicine and is not available in pharmacies. Any distribution is as research material not intended for human use. Human use is not legally provided for.

Can I get CJC-1295 DAC at a pharmacy?+

No. There is no approved finished pharmaceutical containing it, so pharmacies do not regularly stock it.

What's the difference between CJC-1295 with and without DAC?+

The DAC modification extends duration by binding to albumin. Without DAC (Mod GRF 1-29), the action is short and pulsatile.

Related peptides

This site is intended for factual information only. It is not medical advice. This site sells no substances and names no sources.